AbbVie (ABBV) Net Shares Issued and Repurchased (2013 - 2016)
AbbVie's (ABBV) quarterly Net Shares Issued and Repurchased came in at $231000.0 in Q1 2016, up 49.03% year-over-year from $155000.0 in Q2 2015, and down 65.78% quarter-over-quarter from $675000.0 in Q4 2015.
Analysis
AbbVie (ABBV) Net Shares Issued and Repurchased (2013 - 2016) Analysis & Trends
AbbVie (ABBV) has reported Net Shares Issued and Repurchased for 4 consecutive years, with $231000.0 the latest figure, recorded in Q1 2016.
- On a quarterly basis, Net Shares Issued and Repurchased rose 49.03% year-over-year to $231000.0 in Q1 2016; TTM through Mar 2016 was $231000.0, a 49.03% increase from a year earlier, with the FY2015 full-year figure at $675000.0, up 18.63% from the prior year.
- Net Shares Issued and Repurchased was $231000.0 for Q1 2016 at AbbVie, down from $675000.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $675000.0 in Q4 2015 and troughed at $76000.0 in Q1 2013.
- A 4-year average of $339428.6 and a median of $231000.0 in 2016 frame the typical range for Net Shares Issued and Repurchased.
- The widest YoY moves for Net Shares Issued and Repurchased: up 63.16% in 2014, down 4.21% in 2014.
- Over 4 years, Net Shares Issued and Repurchased stood at $546000.0 in 2013, then grew by 4.21% to $569000.0 in 2014, then advanced by 18.63% to $675000.0 in 2015, then tumbled by 65.78% to $231000.0 in 2016.
- The last three Net Shares Issued and Repurchased figures came in at $231000.0 (Q1 2016), $675000.0 (Q4 2015), and $155000.0 (Q1 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | 231,000.00 |
| Dec 31, 2015 | 675,000.00 |
| Mar 31, 2015 | 155,000.00 |
| Dec 31, 2014 | 569,000.00 |
| Mar 31, 2014 | 124,000.00 |
| Dec 31, 2013 | 546,000.00 |
| Mar 31, 2013 | 76,000.00 |